-
Title rivals Djokovic and Sinner advance at Wimbledon
-
Record-equalling Djokovic powers into Wimbledon last 16
-
Ferrari confirm Hamilton staying next year
-
Ruthless Sinner powers into Wimbledon last 16
-
Global frenzy over Swift, Kelce's glittering 'royal wedding'
-
England's Kane feels 'as good as ever' ahead of Mexico World Cup clash
-
Three acquitted of 2019 murder of N.Irish journalist Lyra McKee
-
French Top 14 champions Toulouse fined for salary breaches
-
Stokes bids farewell to fans after 'mad 15 years'
-
Thousands more head for South Africa's borders
-
One for the history books: what we know about the European heatwave
-
Australia upbeat about 'ultimate professional' Perry's fitness for World Cup final
-
Dutch FA to sue over racist slurs after World Cup exit
-
Ukraine backers to vow major support at NATO summit
-
Mercedes demos set stage for wave of German auto protests
-
Ayuso happy to fly under radar at Tour de France
-
Iran leaders pay last respects to Khamenei as mourners gather
-
Curran ready to fill England gap left by Stokes exit
-
UN issues 'red alert' over 'catastrophe' in Sudan's El-Obeid
-
Djokovic has history on the line at Wimbledon
-
Tour de France to start with team time-trial 'bang'
-
Hamilton sparkles in Silverstone sunshine
-
Dressed for success: Osaka reaches Wimbledon last 16 for first time
-
Swift and Kelce set to tie the knot in glitzy arena extravaganza
-
Bayern sign Germany defender Brown until 2031
-
Police hunt for Ukrainian woman over Monaco bomb attack
-
MEXC's June Highlights: $437 Billion in Trading Volume, Offering Access to 7,000+ US Stocks and ETFs
-
Kenya's abortion taboo is killing thousands of women
-
Stocks mostly rise as beaten-down tech stocks enjoy bounce
-
Madonna returns to form with dancefloor filler "Confessions II"
-
Iranian leaders pay respects to supreme leader as Tehran prepares for funeral
-
Dean says Australia final a 'fresh start' for England
-
Doubles not a 'carnival sideshow' say players amid schedule row
-
Wimbledon giving Serena 'as much time' as possible for doubles
-
Klopp in 'talks' for Germany job after Nagelsmann exit: federation
-
Chinese investors flock to Hong Kong as trading curbs tighten
-
Surging real estate development divides opinion on Athens' riviera
-
Projected 'super typhoon' heads for US Pacific islands
-
Move over, Messi! Robot footballers thrill crowds in South Korea
-
UN warns of strong looming El Nino
-
France deaths rose by 30% during heatwave
-
Hunt for last signs of life in Venezuela quake zone
-
Drones spot sharks 73 times in two days off Sydney beaches
-
Asian markets rise as beaten-down tech stocks enjoy bounce
-
Supreme leader's body arrives at Tehran religious complex for funeral
-
David v Goliath as Cape Verde face Messi's Argentina at World Cup
-
Mbappe's French juggernaut face Paraguay, eye World Cup quarter-finals
-
Nagelsmann quits as Germany coach after World Cup exit: reports
-
Wallabies riding wave of patriotic support against Ireland
-
All Blacks return to Christchurch 'a blessing', says Savea
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
T.Perez--AT